Top Suppliers:I want be here

957-75-5

957-75-5 structure
957-75-5 structure
  • Name: 5-Bromouridine
  • Chemical Name: 5-bromouridine
  • CAS Number: 957-75-5
  • Molecular Formula: C9H11BrN2O6
  • Molecular Weight: 323.10
  • Catalog: Biochemical Nucleoside drugs Nucleoside intermediate
  • Create Date: 2018-05-06 08:00:00
  • Modify Date: 2026-06-30 19:55:21
  • 5-Bromouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name 5-bromouridine
Synonyms 5-Bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3
5-bromo-uridin
5-Br-rU
5-Bromouridine //BP
5-Bromouracil ribonucleoside
5-Bromo-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
5-bromouracil-1-β-d-ribofuranoside
5-BrU
()-5-Bromouridine
5-Bromouracil-1-β-D-ribofuranoside, 5-Bromouridine
5-BROMOURIDINE extrapure
5-BROMOURACIL-1-BETA-D-RIBOFURANOSIDE
5-BROMOURIDINE (5-BROMOURACIL-1-β-D-RIBOFURANOSIDE: 5-BRU)
5-BroMo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione
5-Bromouracil-1-β-D-ribofuranoside
5-BROMO-URIDINE(5-BRU)
5-bromo-UMP
MFCD00006528
1-β-ribofuranosyl-5-bromo-uracil
(-)-5-BROMOURIDINE
5-BROMOURIDINE
EINECS 213-486-6
5-broMo-1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxyMethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyriMidine-2,4-dione
5-Br-Ur
bromouridine
5-broMo-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyriMidine-2,4-dione
5-Br-Uridine
5'-BROMOURIDINE
1-beta-ribofuranosyl-5-bromo-uracil
Uridine, 5-bromo
5-Bromouridine >
5-Bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1
5-Bromo-D-uridine
Description 5-Bromouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

Density 2.0±0.1 g/cm3
Melting Point 180-182 °C (dec.)(lit.)
Molecular Formula C9H11BrN2O6
Molecular Weight 323.10
Exact Mass 321.980042
PSA 124.78000
LogP -0.92
Index of Refraction 1.691

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YU7300000
CHEMICAL NAME :
Uridine, 5-bromo-
CAS REGISTRY NUMBER :
957-75-5
BEILSTEIN REFERENCE NO. :
0033664
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C9-H11-Br-N2-O6
MOLECULAR WEIGHT :
323.13
WISWESSER LINE NOTATION :
T6NVMVJ EE A- BT5OTJ CQ DQ E1Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
20 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- Volume(issue)/page/year: 43,205,1980
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- Volume(issue)/page/year: 43,205,1980
Hazard Codes Xn
Safety Phrases S22-S24/25
WGK Germany 3
RTECS YU7300000

~97%

957-75-5 structure

957-75-5

Literature: Kumar; Wiebe; Knaus Canadian Journal of Chemistry, 1994 , vol. 72, # 9 p. 2005 - 2010

~85%

957-75-5 structure

957-75-5

Literature: Asakura, Jun-ichi; Robins, Morris J. Journal of Organic Chemistry, 1990 , vol. 55, # 16 p. 4928 - 4933

~58%

957-75-5 structure

957-75-5

Literature: Synthesis, , vol. No. 9, p. 829 - 831

~%

957-75-5 structure

957-75-5

Literature: Journal of Organic Chemistry, , vol. 55, # 16 p. 4928 - 4933

~%

957-75-5 structure

957-75-5

Literature: Bioorganic and Medicinal Chemistry, , vol. 20, # 24 p. 7184 - 7193

~%

957-75-5 structure

957-75-5

Literature: Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, , vol. 40, # 9 p. 768 - 775
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.